Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    87,578.74
    -2,341.68 (-2.60%)
     

  • CMC Crypto 200

    1,371.97
    +59.35 (+4.52%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

The Global Antifungal Drugs Market is expected to grow by USD 2.50 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period

ReportLinker
·2 min read

Global Antifungal Drugs Market 2020-2024 The analyst has been monitoring the antifungal drugs market and it is poised to grow by USD 2. 50 bn during 2020-2024 progressing at a CAGR of 4% during the forecast period.

New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Antifungal Drugs Market 2020-2024" - https://www.reportlinker.com/p04793460/?utm_source=GNW
Our reports on antifungal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of fungal infections, emerging new targets for the treatment of resistant fungal infections and an increase in antifungal research funding. In addition, the increasing prevalence of fungal infections is anticipated to boost the growth of the market as well.
The antifungal drugs market analysis includes the route of administration segment and geographical landscapes.

The antifungal drugs market is segmented as below:
By Route of administration
• Topical
• Oral
• Parenteral

By Geographical Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the use of antifungal combinations as one of the prime reasons driving the antifungal drugs market growth during the next few years. Also, use of immunomodulatory therapies for fungal infection and increasing awareness about fungal infections will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our antifungal drugs market covers the following areas:
• Antifungal drugs market sizing
• Antifungal drugs market forecast
• Antifungal drugs market industry analysis


Read the full report: https://www.reportlinker.com/p04793460/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001